Atlas Trials

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.

Clinical trial NCT00799747 · COMPLETED

Trial details

NCT number
NCT00799747
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-12-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.